A detailed history of Gsa Capital Partners LLP transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 149,968 shares of ASRT stock, worth $145,468. This represents 0.01% of its overall portfolio holdings.

Number of Shares
149,968
Holding current value
$145,468
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$1.07 - $1.75 $160,465 - $262,444
149,968 New
149,968 $177,000
Q1 2023

May 12, 2023

BUY
$3.54 - $6.66 $283,773 - $533,878
80,162 New
80,162 $510,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $46.7M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.